Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Real World Study of Neoadjuvant Immunotherapy in Early Stage NSCLC in China

NCT04286841 is registered in ClinicalTrials.gov with Guangdong Association of Clinical Trials as lead sponsor.

NCT NCT04286841
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04286841 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Real World Study of Neoadjuvant Immunotherapy in Early Stage NSCLC in China
Lead sponsor
Guangdong Association of Clinical Trials
Phase
Observational
Overall status
Recruiting
Start date
May 1, 2019
Completion date
December 31, 2029
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

immunotherapy, lung cancer